PL1808442T3 - Enzymatyczna synteza glikokoniugatów mucyny na dużą skalę i ich zastosowanie immunogenne - Google Patents

Enzymatyczna synteza glikokoniugatów mucyny na dużą skalę i ich zastosowanie immunogenne

Info

Publication number
PL1808442T3
PL1808442T3 PL06290091T PL06290091T PL1808442T3 PL 1808442 T3 PL1808442 T3 PL 1808442T3 PL 06290091 T PL06290091 T PL 06290091T PL 06290091 T PL06290091 T PL 06290091T PL 1808442 T3 PL1808442 T3 PL 1808442T3
Authority
PL
Poland
Prior art keywords
mucin
glyconjugates
scale synthesis
applications
immunogenic
Prior art date
Application number
PL06290091T
Other languages
English (en)
Inventor
Sylvie Bay
Teresa Freire
Claude Leclerc
Richard Lo-Man
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Centre Nat Rech Scient, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Publication of PL1808442T3 publication Critical patent/PL1808442T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A61K39/00117—Mucins, e.g. MUC-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL06290091T 2006-01-13 2006-01-13 Enzymatyczna synteza glikokoniugatów mucyny na dużą skalę i ich zastosowanie immunogenne PL1808442T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06290091A EP1808442B1 (en) 2006-01-13 2006-01-13 Enzymatic large-scale synthesis of mucin glyconjugates, and immunogenic applications thereof

Publications (1)

Publication Number Publication Date
PL1808442T3 true PL1808442T3 (pl) 2011-12-30

Family

ID=36160509

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06290091T PL1808442T3 (pl) 2006-01-13 2006-01-13 Enzymatyczna synteza glikokoniugatów mucyny na dużą skalę i ich zastosowanie immunogenne

Country Status (8)

Country Link
US (1) US9657074B2 (pl)
EP (1) EP1808442B1 (pl)
JP (1) JP5231247B2 (pl)
AT (1) ATE509027T1 (pl)
CA (1) CA2631582C (pl)
ES (1) ES2366552T3 (pl)
PL (1) PL1808442T3 (pl)
WO (1) WO2007079783A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008007941A1 (en) * 2006-07-10 2008-01-17 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Gainac specific binding molecules and uses thereof
WO2010001908A1 (ja) * 2008-06-30 2010-01-07 協和発酵キリン株式会社 抗cd27抗体
US9588121B2 (en) 2009-11-06 2017-03-07 Go Therapeutics, Inc. Method for early detection of cancer
KR101773216B1 (ko) * 2009-12-29 2017-08-31 교와 핫꼬 기린 가부시키가이샤 항 ｃｄ27 항체
CN102296052B (zh) * 2011-08-17 2013-04-10 上海交通大学 一种针对ppGalNAc-T13多克隆抗体的特异性抗原肽及其制备与应用
WO2013151649A1 (en) 2012-04-04 2013-10-10 Sialix Inc Glycan-interacting compounds
WO2013161614A1 (ja) 2012-04-27 2013-10-31 コニカミノルタ株式会社 酵素処理工程を含むレクチンを用いた抗原検出方法
JP6323463B2 (ja) 2013-12-27 2018-05-16 コニカミノルタ株式会社 診断用情報の分析方法およびそのためのキット
EP3088896B1 (en) 2013-12-27 2019-11-06 Konica Minolta, Inc. Method for analyzing information for diagnosis and kit therefor
HUE061672T2 (hu) 2014-11-12 2023-08-28 Seagen Inc Glikán-interakcióban lévõ vegyületek és felhasználási módszerek
US9879087B2 (en) 2014-11-12 2018-01-30 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
JP7066613B2 (ja) 2015-11-12 2022-05-13 シージェン インコーポレイテッド グリカン相互作用化合物および使用方法
WO2018094143A1 (en) 2016-11-17 2018-05-24 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
KR102653141B1 (ko) 2017-03-03 2024-04-01 씨젠 인크. 글리칸-상호작용 화합물 및 사용 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660834A (en) 1988-03-11 1997-08-26 The Biomembrane Institute Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with carbohydrate-carrier conjugates
ATE328611T1 (de) 1997-03-27 2006-06-15 Pasteur Institut Multiple,kohlenhydrathaltige glycopeptid-antigene,daraus entwickelte impfstoffe sowie deren verwendung
WO1998046246A1 (en) 1997-04-16 1998-10-22 Sloan-Kettering Institute For Cancer Research α-O-LINKED GLYCOCONJUGATES WITH CLUSTERED (2,6)-ST EPITOPES, METHODS OF PREPARATION AND USES THEREOF
AU4070500A (en) * 1999-04-05 2000-10-23 Biocrystal Limited Assay kits and methods for immune complex-mediated activation involving shed antigens
CA2514986A1 (en) * 2003-02-05 2004-08-19 Applied Research Systems Ars Holding N.V. Mucin-like polypeptides
EP1809758A4 (en) * 2004-10-20 2009-04-01 Scripps Research Inst LOCAL IN VIVO INSTALLATION OF N-ACETYLGALACTOSAMINE AMINO ACIDS IN EU BACTERIA

Also Published As

Publication number Publication date
US20100272707A1 (en) 2010-10-28
CA2631582C (en) 2014-04-08
WO2007079783A1 (en) 2007-07-19
ATE509027T1 (de) 2011-05-15
JP5231247B2 (ja) 2013-07-10
US9657074B2 (en) 2017-05-23
CA2631582A1 (en) 2007-07-19
JP2009523137A (ja) 2009-06-18
EP1808442A1 (en) 2007-07-18
EP1808442B1 (en) 2011-05-11
ES2366552T3 (es) 2011-10-21

Similar Documents

Publication Publication Date Title
PL1808442T3 (pl) Enzymatyczna synteza glikokoniugatów mucyny na dużą skalę i ich zastosowanie immunogenne
PT1928882E (pt) (s)-n-metilnaltrexona, processo para a sua síntese e sua utilização farmacêutica
PH12013502192A1 (en) Antibodies against human angiopoietin 2
WO2005063820A3 (en) Il-7 fusion proteins
GB0619291D0 (en) Altered antibodies
BRPI1010637A2 (pt) suplementos nutricionais orais compreendendo probióticos
WO2009010877A3 (en) Conjugate purification
MX2010003574A (es) Anticuerpos il-23.
EA201070003A1 (ru) Эпихлоргидрин, способ получения и применение
TW201129381A (en) Antibodies against human CSF-1R and uses thereof
IL222787A0 (en) Process for preparing nebivolol
IL265947A (en) Preparation of stansoporfin with a high degree of purification on a large scale
ATE493893T1 (de) Feste enymformulierungen und verfahren zu deren herstellung
WO2011003965A3 (fr) Dispositif de séparation linéaire douce d'une première pièce et d'une seconde pièce
MY148276A (en) Long-term feed- elderly
BRPI0408848B8 (pt) composições farmacêuticas de complexo de ciclodextrina-cladribina complexo, usos do referido complexo, bem como processos para a sua preparação
NO20091140L (no) Fremgangsmate for fremstilling av polyester nanokompositter
BR0207447A (pt) Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina
MY162125A (en) A process for producing a biomass containing astaxanthin
TH132857A (th) องค์ประกอบโภชนาการ
WO2007034183A3 (en) Process for the preparation of 4-aminopyrazole derivatives
DE602007009713D1 (en) Cross-spot
WO2008076490A3 (en) Histophilus somni antigens, compositions and methods of use
TH79576A (th) กรรมวิธีในการรวมแอนติบอดี้และผลิตภัณฑ์ที่ใช้ในการรักษาโรคซึ่งได้จากกรรมวิธีดังกล่าว
GR1005526B (el) Υλικο και μεθοδος για την απομακρυνση κυκλοδεξτρινων και αλλων μεγαλομοριων απο διαφορα προϊοντα